AI in Radiology Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)
The global AI in Radiology Market size is forecast to increase from $18.8 Billion in 2026 to $217.45 Billion in 2034 at a CAGR of 35.8% between 2026 and 2034.
The AI in Radiology market report provides detailed analysis and outlook of AI in Radiology segments including By Modality (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-Ray and Mammography, Ultrasound, Molecular Imaging and PET), By Application (Neurology and Neuroradiology, Oncology, Cardiovascular and Vascular Imaging, Musculoskeletal (MSK) Radiology, Chest and Respiratory Imaging, Breast Imaging ), By Deployment Mode (Cloud-Based Platforms, On-Premise ), By Core Functionality (Image Acquisition and Optimization, Computer-Aided Detection (CADe) and Diagnosis (CADx), Automated Segmentation and Quantification, Triage and Workflow Prioritization, Automated Reporting and Clinical Documentation), By End-User (Hospitals and Trauma Centers, Diagnostic Imaging Centers, Ambulatory Surgical Centers (ASCs), Research Institutes and Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
AI in Radiology Industry Overview
The AI in Radiology industry is advancing rapidly as healthcare providers, imaging networks, and clinical research organizations adopt artificial intelligence to improve diagnostic workflows, enhance imaging quality control, and optimize radiology operations. AI technologies are increasingly being integrated into radiology platforms to automate repetitive tasks, support radiologist productivity, accelerate clinical decision-making, and improve patient outcomes. The industry is also witnessing growing adoption of cloud-native architectures and agentic AI frameworks that enable seamless workflow orchestration across large-scale healthcare environments.
Strategic Partnerships Accelerating Enterprise AI Adoption
A major development in the AI in Radiology market is the strategic partnership between Sirona Medical and Everlight Radiology. Through a five-year agreement, Everlight Radiology is deploying Sirona Medical’s RadOS platform across its global operations spanning the United Kingdom, Ireland, Australia, New Zealand, the United Arab Emirates, and South Africa. RadOS is a cloud-native radiology operating system that incorporates an agentic AI orchestration layer designed to automate both clinical and administrative workflows. The platform will support more than 800 radiologists across Everlight’s international network, highlighting the growing demand for enterprise-scale AI solutions capable of streamlining radiology reporting, workflow management, and operational efficiency. The adoption of agentic AI within radiology infrastructure reflects a broader industry movement toward intelligent automation and integrated healthcare delivery systems.
AI-Powered Imaging Solutions Enhancing Clinical Trial Efficiency
Artificial intelligence is also transforming medical imaging workflows within oncology research and clinical trials. Medidata introduced an enhanced AI-powered imaging solution designed to improve imaging quality control processes during clinical studies. The platform automates patient identity verification and contrast administration checks, delivering near-immediate feedback on imaging quality. By reducing manual review requirements and accelerating image validation, the solution supports faster oncology trial assessments and improves operational consistency across research sites. The increasing integration of AI into clinical trial imaging workflows demonstrates the industry's focus on improving data integrity, accelerating study timelines, and supporting more efficient drug development programs.
AI-Enabled Intraoperative Imaging Expanding Cancer Care Applications
Innovation in AI-guided imaging devices is creating new opportunities within surgical oncology. Perimeter Medical Imaging AI received FDA premarket approval for Claire, an AI-enabled imaging platform developed for intraoperative breast cancer margin assessment. The device provides surgeons with advanced imaging capabilities to evaluate excised tissue during breast-conserving procedures, helping identify residual cancer at the surgical margin. Following regulatory approval, Perimeter Medical Imaging AI reported the first clinical placements of Claire and confirmed ongoing expansion across leading healthcare institutions in the United States. The commercialization of AI-powered intraoperative imaging technologies highlights the increasing role of artificial intelligence in supporting precision surgery, improving procedural outcomes, and reducing the need for repeat operations.
AI in Radiology Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global AI in Radiology market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Aidoc, Viz.ai, Inc., Lunit Inc., Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Zebra Medical Vision (Nanox AI), Annalise.ai, Gleamer, Rad AI. The AI in Radiology market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the AI in Radiology industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
-
Growth AI in Radiology Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
-
Market Trends, Drivers, Potential Opportunities, and Challenges faced by AI in Radiology companies
-
Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
-
Detailed SWOT Analysis of global and regional AI in Radiology markets
-
Competitive analysis including business description, product analysis, and financial profiles
-
Key country specific analysis detailing key factors shaping the short-term and long-term outlook
-
Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
AI in Radiology Market Competitive Benchmarking and Company Analysis
Leading companies in AI in Radiology industry include- Aidoc, Viz.ai, Inc., Lunit Inc., Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Zebra Medical Vision (Nanox AI), Annalise.ai, Gleamer, Rad AI. The AI in Radiology market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US AI in Radiology Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the AI in Radiology market remains one of the strongest-performing segments in the country.
The US AI in Radiology Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US AI in Radiology market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across AI in Radiology industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian AI in Radiology markets
Canada's strong AI in Radiology sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian AI in Radiology market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany AI in Radiology Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest AI in Radiology market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of AI in Radiology population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany AI in Radiology industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the AI in Radiology market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support AI in Radiology sales through 2034
France AI in Radiology companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK AI in Radiology Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of AI in Radiology distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China AI in Radiology Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China AI in Radiology market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of AI in Radiology industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese AI in Radiology industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India AI in Radiology Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian AI in Radiology market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil AI in Radiology market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa AI in Radiology Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
AI in Radiology Market Segmentation
By Modality
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
X-Ray and Mammography
Ultrasound
Molecular Imaging and PET
By Application
Neurology and Neuroradiology
Oncology
Cardiovascular and Vascular Imaging
Musculoskeletal (MSK) Radiology
Chest and Respiratory Imaging
Breast Imaging
By Deployment Mode
Cloud-Based Platforms
On-Premise
By Core Functionality
Image Acquisition and Optimization
Computer-Aided Detection (CADe) and Diagnosis (CADx)
Automated Segmentation and Quantification
Triage and Workflow Prioritization
Automated Reporting and Clinical Documentation
By End-User
Hospitals and Trauma Centers
Diagnostic Imaging Centers
Ambulatory Surgical Centers (ASCs)
Research Institutes and Laboratories
Top Companies in AI in Radiology Industry
Aidoc
Viz.ai, Inc.
Lunit Inc.
Siemens Healthineers AG
GE HealthCare
Koninklijke Philips N.V.
Zebra Medical Vision (Nanox AI)
Annalise.ai
Gleamer
Rad AI
Countries Included
-
North America- US, Canada, Mexico
-
Europe- Germany, France, UK, Spain, Italy, Nordics, Others
-
Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
-
Latin America- Brazil, Argentina, Others
-
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Latest Market Updates In Healthcare
Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.
Low MOQ, High-Mix Production Models for Indie & DTC Brands
The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...
Market UpdateRise of Functional and Clinical-Grade Skincare
The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...
By Modality
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
X-Ray and Mammography
Ultrasound
Molecular Imaging and PET
By Application
Neurology and Neuroradiology
Oncology
Cardiovascular and Vascular Imaging
Musculoskeletal (MSK) Radiology
Chest and Respiratory Imaging
Breast Imaging
By Deployment Mode
Cloud-Based Platforms
On-Premise
By Core Functionality
Image Acquisition and Optimization
Computer-Aided Detection (CADe) and Diagnosis (CADx)
Automated Segmentation and Quantification
Triage and Workflow Prioritization
Automated Reporting and Clinical Documentation
By End-User
Hospitals and Trauma Centers
Diagnostic Imaging Centers
Ambulatory Surgical Centers (ASCs)
Research Institutes and Laboratories